Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: results from a large-scale longitudinal cohort study
Journal of Global Health · 2025
DOI: 10.7189/jogh.15.04228 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Global Health, 2025. Verfasst von Xiaoyang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Leukocytes, Telomere. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Previous studies on the correlation between leukocyte telomere length (LTL) and prostate cancer (PCa) have shown inconsistent results. We aimed to clarify this association by leveraging a large-scale prospective design and Mendelian randomisation.
Methods
We enrolled a total of 229 022 male individuals from the UK Biobank (UKB) to investigate the association between LTL and PCa risk. We employed both unadjusted and covariates-adjusted Cox proportional hazards regression models to assess this relationship. We defined the primary outcome as the diagnosis of incident PCa using in-patient data and the death registry of the UK Biobank cohort. To validate the reliability of the primary findings, we conducted secondary analyses, including Mendelian randomisation.
Results
The primary analysis demonstrated that longer LTL was substantially associated with higher risk of PCa, with associations remaining robust after adjusting for potential covariates (hazard ratio (HR) = 1.444; 95% confidence interval (CI) = 1.247, 1.673, P < 0.001). We observed similar results when LTL was analysed as both a continuous and categorical variable, and the association was shown to be inversely U-shaped. We further validated the association at the genetic level using Mendelian randomisation across different PCa databases, with results consistent with our primary analysis.
Conclusions
Our findings offer evidence that leukocyte telomere length is an important risk factor for PCa. Further studies are needed to elucidate the underlying mechanisms linking leukocyte telomere length to PCa risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
- Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Liu, X., Liu, S., Yu, Y., Song, P., Yang, L., Liu, Z., Zhou, J., Yan, X., Ma, K., Qiu, H., Wang, X., & Dong, Q. (2025). Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: results from a large-scale longitudinal cohort study. Journal of Global Health. https://doi.org/10.7189/jogh.15.04228
Vancouver
Liu X, Liu S, Yu Y, Song P, Yang L, Liu Z, et al. Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: results from a large-scale longitudinal cohort study. Journal of Global Health. 2025. doi:10.7189/jogh.15.04228
BibTeX
@article{Liu2025,
author = {Liu, Xiaoyang and Liu, Shengzhuo and Yu, Yunfei and Song, Pan and Yang, Luchen and Liu, Zhenghuan and Zhou, Jing and Yan, Xin and Ma, Kai and Qiu, Haiyun and Wang, Xianding and Dong, Qiang},
title = {Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: results from a large-scale longitudinal cohort study},
journal = {Journal of Global Health},
year = {2025},
doi = {10.7189/jogh.15.04228}
}
EUVIMED